A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis

BACKGROUND: The present study was designed to investigate the efficacy of a new formulation of alone, purified cannabidiol (CBD) (>98 %), the main non-psychotropic cannabinoid of Cannabis sativa, as a topical treatment in an experimental model of autoimmune encephalomyelitis (EAE), the most commo...

Descripción completa

Detalles Bibliográficos
Autores principales: Giacoppo, Sabrina, Galuppo, Maria, Pollastro, Federica, Grassi, Gianpaolo, Bramanti, Placido, Mazzon, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618347/
https://www.ncbi.nlm.nih.gov/pubmed/26489494
http://dx.doi.org/10.1186/s40199-015-0131-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618347/
https://www.ncbi.nlm.nih.gov/pubmed/26489494
http://dx.doi.org/10.1186/s40199-015-0131-8

Ejemplares similares